Global seroprevalence of SARS-CoV-2 antibodies: a systematic review and meta-analysis

Niklas Bobrovitz, Rahul Krishan Arora, Christian Cao, Emily Boucher, Michael Liu, Claire Donnici, Mercedes Yanes-Lane, Mairead Whelan, Sara Perlman-Arrow, Judy Chen, Hannah Rahim, Natasha Ilincic, Mitchell Segal, Nathan Duarte, Jordan Van Wyk, Tingting Yan, Austin Atmaja, Simona Rocco, Abel Joseph, Lucas Penny, David A. Clifton, Tyler Williamson, Cedric P Yansouni, Timothy Grant Evans, Jonathan Chevrier, Jesse Papenburg, Matthew P. Cheng
doi: https://doi.org/10.1101/2020.11.17.20233460

Article Information

doi 
https://doi.org/10.1101/2020.11.17.20233460
History 
  • May 16, 2021.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Niklas Bobrovitz1,2,*,,
  2. Rahul Krishan Arora3,4,,
  3. Christian Cao5,
  4. Emily Boucher5,
  5. Michael Liu6,
  6. Claire Donnici5,
  7. Mercedes Yanes-Lane7,
  8. Mairead Whelan5,
  9. Sara Perlman-Arrow8,
  10. Judy Chen9,
  11. Hannah Rahim5,
  12. Natasha Ilincic1,
  13. Mitchell Segal1,
  14. Nathan Duarte10,
  15. Jordan Van Wyk10,
  16. Tingting Yan1,
  17. Austin Atmaja10,
  18. Simona Rocco10,
  19. Abel Joseph10,
  20. Lucas Penny1,
  21. David A. Clifton2,
  22. Tyler Williamson4,
  23. Cedric P Yansouni11,12,
  24. Timothy Grant Evans8,
  25. Jonathan Chevrier13,
  26. Jesse Papenburg14,& and
  27. Matthew P. Cheng12,&
  1. 1Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
  2. 2Department of Critical Care Medicine, University of Calgary, Calgary, Alberta, Canada
  3. 3Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, UK
  4. 4Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada
  5. 5Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
  6. 6Department of Social Policy and Intervention, University of Oxford, Oxford, UK
  7. 7COVID-19 Immunity Task Force, McGill University, Montreal, Quebec, Canada
  8. 8School of Population and Global Health, McGill University, Montreal, Quebec, Canada
  9. 9Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada
  10. 10Faculty of Engineering, University of Waterloo, Waterloo, Ontario, Canada
  11. 11JD MacLean Centre for Tropical Diseases, McGill University, Montreal, Quebec, Canada
  12. 12Divisions of Infectious Diseases and Medical Microbiology, McGill University Health Centre, Montreal, Quebec, Canada
  13. 13Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University, Montreal, Quebec, Canada
  14. 14Division of Pediatric Infectious Diseases, Deptartment of Pediatrics, McGill University Health Centre, Montreal, Quebec, Canada
  1. ↵*Corresponding author E-mail: niklas.bobrovitz{at}mail.utoronto.ca (NB)

  1. ↵ NB and RKA contributed equally to this paper as co-first authors.

  2. ↵& JP and MPC contributed equally to this paper as co-senior authors.

Back to top
Posted May 16, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Global seroprevalence of SARS-CoV-2 antibodies: a systematic review and meta-analysis
Niklas Bobrovitz, Rahul Krishan Arora, Christian Cao, Emily Boucher, Michael Liu, Claire Donnici, Mercedes Yanes-Lane, Mairead Whelan, Sara Perlman-Arrow, Judy Chen, Hannah Rahim, Natasha Ilincic, Mitchell Segal, Nathan Duarte, Jordan Van Wyk, Tingting Yan, Austin Atmaja, Simona Rocco, Abel Joseph, Lucas Penny, David A. Clifton, Tyler Williamson, Cedric P Yansouni, Timothy Grant Evans, Jonathan Chevrier, Jesse Papenburg, Matthew P. Cheng
medRxiv 2020.11.17.20233460; doi: https://doi.org/10.1101/2020.11.17.20233460
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area